Hipertenzija (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hipertenzija" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

75nih.gov

4^th place

3^rd place

50doi.org

2^nd place

10archive.org

6^th place

5^th place

7web.archive.org

1^st place

7ahajournals.org

3,608^th place

1,651^st place

4nice.org.uk

3,258^th place

1,943^rd place

3archive.today

14^th place

30^th place

2medscape.com

719^th place

171^st place

1chestpubs.org

low place

309^th place

1who.int

195^th place

70^th place

1nps.org.au

low place

1wiley.com

222^nd place

57^th place

1australianprescriber.com

low place

9,126^th place

1hta.ac.uk

low place

1webmd.com

1,169^th place

964^th place

1bnf.org

low place

1aafp.org

1,916^th place

1,195^th place

1sagepub.com

731^st place

1,123^rd place

aafp.org

Luma GB, Spiotta RT (May 2006). „Hypertension in children and adolescents”. Am Fam Physician 73 (9): 1558–68. PMID 16719248. Arhivirano iz originala na datum 2007-09-26. Pristupljeno 2013-09-23.

ahajournals.org

archive.org

O'Brien, Eoin; Beevers, D. G.; Lip, Gregory Y. H. (2007). ABC of hypertension. London: BMJ Books. ISBN 1-4051-3061-X.
Grossman E, Messerli FH (January 2012). „Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension”. Am. J. Med. 125 (1): 14–22. DOI:10.1016/j.amjmed.2011.05.024. PMID 22195528.
Conway J (April 1984). „Hemodynamic aspects of essential hypertension in humans”. Physiol. Rev. 64 (2): 617–60. PMID 6369352.
Safar ME, London GM (August 1987). „Arterial and venous compliance in sustained essential hypertension”. Hypertension 10 (2): 133–9. PMID 3301662.
Zieman SJ, Melenovsky V, Kass DA (May 2005). „Mechanisms, pathophysiology, and therapy of arterial stiffness”. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932–43. DOI:10.1161/01.ATV.0000160548.78317.29. PMID 15731494.
Navar LG (December 2010). „Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998–2000; discussion 2015. DOI:10.1152/japplphysiol.00182.2010a. PMC 3006411. PMID 21148349.
Esler M, Lambert E, Schlaich M (December 2010). „Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1996–8; discussion 2016. DOI:10.1152/japplphysiol.00182.2010. PMID 20185633.
Calhoun DA, Jones D, Textor S i dr.. (June 2008). „Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research”. Hypertension 51 (6): 1403–19. DOI:10.1161/HYPERTENSIONAHA.108.189141. PMID 18391085.
Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S (July 2007). „Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004”. Journal of the American Geriatrics Society 55 (7): 1056–65. DOI:10.1111/j.1532-5415.2007.01215.x. PMID 17608879.
Swales JD, ur. (1995). Manual of hypertension. Oxford: Blackwell Science. str. xiii. ISBN 0-86542-861-1.

archive.today

Burt VL, Whelton P, Roccella EJ i dr.. (March 1995). „Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991”. Hypertension 25 (3): 305–13. PMID 7875754. Arhivirano iz originala na datum 2012-12-05. Pristupljeno 2009-06-05.
Burt VL, Cutler JA, Higgins M i dr.. (July 1995). „Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991”. Hypertension 26 (1): 60–9. PMID 7607734. Arhivirano iz originala na datum 2012-12-20. Pristupljeno 2009-06-05.
Alcocer L, Cueto L (June 2008). „Hypertension, a health economics perspective”. Therapeutic Advances in Cardiovascular Disease 2 (3): 147–55. DOI:10.1177/1753944708090572. PMID 19124418. Arhivirano iz originala na datum 2012-12-04. Pristupljeno 2009-06-20.

australianprescriber.com

Nelson, Mark. „Drug treatment of elevated blood pressure”. Australian Prescriber (33): 108–112. Pristupljeno 2010-08-11.

bnf.org

„2.5.5.1 Angiotensin-converting enzyme inhibitors”. British National Formulary. No. 62. 2011. Arhivirano iz originala na datum 2021-12-23. Pristupljeno 2011-12-22.

chestpubs.org

chestjournal.chestpubs.org

Marik PE, Varon J (June 2007). „Hypertensive crises: challenges and management”. Chest 131 (6): 1949–62. DOI:10.1378/chest.06-2490. PMID 17565029.

doi.org

dx.doi.org

Carretero OA, Oparil S (January 2000). „Essential hypertension. Part I: Definition and etiology”. Circulation 101 (3): 329–35. DOI:10.1161/01.CIR.101.3.329. PMID 10645931.
Chobanian AV, Bakris GL, Black HR, et al. (December 2003). „Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure”. Hypertension 42 (6): 1206–52. DOI:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957.
Mancia G, De Backer G, Dominiczak A, et al. (September 2007). „2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension”. J. Hypertens. 25 (9): 1751–62. DOI:10.1097/HJH.0b013e3282f0580f. PMID 17762635.
Williams B, Poulter NR, Brown MJ, et al. (March 2004). „Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV”. J Hum Hypertens 18 (3): 139–85. DOI:10.1038/sj.jhh.1001683. PMID 14973512.
Dionne JM, Abitbol CL, Flynn JT (January 2012). „Hypertension in infancy: diagnosis, management and outcome”. Pediatr. Nephrol. 27 (1): 17–32. DOI:10.1007/s00467-010-1755-z. PMID 21258818.
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (September 2007). „High blood pressure trends in children and adolescents in national surveys, 1963 to 2002”. Circulation 116 (13): 1488–96. DOI:10.1161/CIRCULATIONAHA.106.683243. PMID 17846287.
Wong T, Mitchell P (February 2007). „The eye in hypertension”. Lancet 369 (9559): 425–35. DOI:10.1016/S0140-6736(07)60198-6. PMID 17276782.
Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T, Papademetriou V (December 2010). „Hypertension crisis”. Blood Press. 19 (6): 328–36. DOI:10.3109/08037051.2010.488052. PMID 20504242.
Marik PE, Varon J (June 2007). „Hypertensive crises: challenges and management”. Chest 131 (6): 1949–62. DOI:10.1378/chest.06-2490. PMID 17565029.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (December 2002). „Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies”. Lancet 360 (9349): 1903–13. DOI:10.1016/S0140-6736(02)11911-8. PMID 12493255.
Singer DR, Kite A (June 2008). „Management of hypertension in peripheral arterial disease: does the choice of drugs matter?”. European Journal of Vascular and Endovascular Surgery 35 (6): 701–8. DOI:10.1016/j.ejvs.2008.01.007. PMID 18375152.
Zeng C, Villar VA, Yu P, Zhou L, Jose PA (April 2009). „Reactive oxygen species and dopamine receptor function in essential hypertension”. Clinical and Experimental Hypertension 31 (2): 156–78. DOI:10.1080/10641960802621283. PMID 19330604.
Haslam DW, James WP (2005). „Obesity”. Lancet 366 (9492): 1197–209. DOI:10.1016/S0140-6736(05)67483-1. PMID 16198769.
Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA et al. (2002). „Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program”. JAMA 288 (15): 1882–8. DOI:10.1001/jama.288.15.1882. PMID 12377087.
Vaidya A, Forman JP (November 2010). „Vitamin D and hypertension: current evidence and future directions”. Hypertension 56 (5): 774–9. DOI:10.1161/HYPERTENSIONAHA.109.140160. PMID 20937970.
Sorof J, Daniels S (October 2002). „Obesity hypertension in children: a problem of epidemic proportions”. Hypertension 40 (4): 441–447. DOI:10.1161/01.HYP.0000032940.33466.12. PMID 12364344. Pristupljeno 2009-06-03.
Grossman E, Messerli FH (January 2012). „Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension”. Am. J. Med. 125 (1): 14–22. DOI:10.1016/j.amjmed.2011.05.024. PMID 22195528.
Chobanian AV (August 2007). „Clinical practice. Isolated systolic hypertension in the elderly”. N. Engl. J. Med. 357 (8): 789–96. DOI:10.1056/NEJMcp071137. PMID 17715411.
Zieman SJ, Melenovsky V, Kass DA (May 2005). „Mechanisms, pathophysiology, and therapy of arterial stiffness”. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932–43. DOI:10.1161/01.ATV.0000160548.78317.29. PMID 15731494.
Navar LG (December 2010). „Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998–2000; discussion 2015. DOI:10.1152/japplphysiol.00182.2010a. PMC 3006411. PMID 21148349.
Esler M, Lambert E, Schlaich M (December 2010). „Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1996–8; discussion 2016. DOI:10.1152/japplphysiol.00182.2010. PMID 20185633.
Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (June 2009). „Endothelium-dependent contractions and endothelial dysfunction in human hypertension”. Br. J. Pharmacol. 157 (4): 527–36. DOI:10.1111/j.1476-5381.2009.00240.x. PMC 2707964. PMID 19630832.
Marchesi C, Paradis P, Schiffrin EL (July 2008). „Role of the renin-angiotensin system in vascular inflammation”. Trends Pharmacol. Sci. 29 (7): 367–74. DOI:10.1016/j.tips.2008.05.003. PMID 18579222.
Padwal RS, Hemmelgarn BR, Khan NA i dr.. (May 2009). „The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 25 (5): 279–86. DOI:10.1016/S0828-282X(09)70491-X. PMC 2707176. PMID 19417858.
Padwal RJ, Hemmelgarn BR, Khan NA i dr.. (June 2008). „The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 24 (6): 455–63. DOI:10.1016/S0828-282X(08)70619-6. PMC 2643189. PMID 18548142.
Padwal RS, Hemmelgarn BR, McAlister FA i dr.. (May 2007). „The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 23 (7): 529–38. DOI:10.1016/S0828-282X(07)70797-3. PMC 2650756. PMID 17534459.
Hemmelgarn BR, McAlister FA, Grover S i dr.. (May 2006). „The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 22 (7): 573–81. DOI:10.1016/S0828-282X(06)70279-3. PMC 2560864. PMID 16755312.
Whelton PK et al. (2002). „Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program”. JAMA 288 (15): 1882–1888. DOI:10.1001/jama.288.15.1882. PMID 12377087.
Siebenhofer, A; Jeitler, K, Berghold, A, Waltering, A, Hemkens, LG, Semlitsch, T, Pachler, C, Strametz, R, Horvath, K (2011-09-07). Siebenhofer, Andrea. ur. „Long-term effects of weight-reducing diets in hypertensive patients”. Cochrane database of systematic reviews (Online) 9: CD008274. DOI:10.1002/14651858.CD008274.pub2. PMID 21901719.
Blumenthal JA, Babyak MA, Hinderliter A i dr.. (January 2010). „Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study”. Arch. Intern. Med. 170 (2): 126–35. DOI:10.1001/archinternmed.2009.470. PMID 20101007.
Rainforth MV, Schneider RH, Nidich SI, Gaylord-King C, Salerno JW, Anderson JW (December 2007). „Stress Reduction Programs in Patients with Elevated Blood Pressure: A Systematic Review and Meta-analysis”. Curr. Hypertens. Rep. 9 (6): 520–8. DOI:10.1007/s11906-007-0094-3. PMC 2268875. PMID 18350109.
Eni C. Okonofua; Kit N. Simpson; Ammar Jesri; Shakaib U. Rehman; Valerie L. Durkalski; Brent M. Egan (2006-01-23). „Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals”. Hypertension 47 (2006;47:345): 345–51. DOI:10.1161/01.HYP.0000200702.76436.4b. PMID 16432045. Pristupljeno 2009-11-22.
Wright JM, Musini VM (2009). Wright, James M. ur. „First-line drugs for hypertension”. Cochrane Database Syst Rev (3): CD001841. DOI:10.1002/14651858.CD001841.pub2. PMID 19588327.
Sever PS, Messerli FH (October 2011). „Hypertension management 2011: optimal combination therapy”. Eur. Heart J. 32 (20): 2499–506. DOI:10.1093/eurheartj/ehr177. PMID 21697169.
Musini VM, Tejani AM, Bassett K, Wright JM (2009). Musini, Vijaya M. ur. „Pharmacotherapy for hypertension in the elderly”. Cochrane Database Syst Rev (4): CD000028. DOI:10.1002/14651858.CD000028.pub2. PMID 19821263.
Aronow WS, Fleg JL, Pepine CJ, et al. (May 2011). „ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension”. J. Am. Coll. Cardiol. 57 (20): 2037–114. DOI:10.1016/j.jacc.2011.01.008. PMID 21524875.
Calhoun DA, Jones D, Textor S i dr.. (June 2008). „Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research”. Hypertension 51 (6): 1403–19. DOI:10.1161/HYPERTENSIONAHA.108.189141. PMID 18391085.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005). „Global burden of hypertension: analysis of worldwide data”. Lancet 365 (9455): 217–23. DOI:10.1016/S0140-6736(05)17741-1. PMID 15652604.
Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S (July 2007). „Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004”. Journal of the American Geriatrics Society 55 (7): 1056–65. DOI:10.1111/j.1532-5415.2007.01215.x. PMID 17608879.
Lloyd-Jones D, Adams RJ, Brown TM, et al. (February 2010). „Heart disease and stroke statistics--2010 update: a report from the American Heart Association”. Circulation 121 (7): e46–e215. DOI:10.1161/CIRCULATIONAHA.109.192667. PMID 20019324.
Falkner B (May 2009). „Hypertension in children and adolescents: epidemiology and natural history”. Pediatr. Nephrol. 25 (7): 1219–24. DOI:10.1007/s00467-009-1200-3. PMC 2874036. PMID 19421783.
Kotchen TA (October 2011). „Historical trends and milestones in hypertension research: a model of the process of translational research”. Hypertension 58 (4): 522–38. DOI:10.1161/HYPERTENSIONAHA.111.177766. PMID 21859967.
Dustan HP, Roccella EJ, Garrison HH (September 1996). „Controlling hypertension. A research success story”. Arch. Intern. Med. 156 (17): 1926–35. DOI:10.1001/archinte.156.17.1926. PMID 8823146.
Novello FC, Sprague JM (1957). „Benzothiadiazine dioxides as novel diuretics”. J. Am. Chem. Soc. 79 (8): 2028. DOI:10.1021/ja01565a079.
Freis ED (1974). „The Veterans Administration Cooperative Study on Antihypertensive Agents. Implications for Stroke Prevention” (PDF). Stroke 5 (1): 76–77. DOI:10.1161/01.STR.5.1.76. PMID 4811316.
Chockalingam A (May 2007). „Impact of World Hypertension Day”. Canadian Journal of Cardiology 23 (7): 517–9. DOI:10.1016/S0828-282X(07)70795-X. PMC 2650754. PMID 17534457.
Chockalingam A (June 2008). „World Hypertension Day and global awareness”. Canadian Journal of Cardiology 24 (6): 441–4. DOI:10.1016/S0828-282X(08)70617-2. PMC 2643187. PMID 18548140.
Alcocer L, Cueto L (June 2008). „Hypertension, a health economics perspective”. Therapeutic Advances in Cardiovascular Disease 2 (3): 147–55. DOI:10.1177/1753944708090572. PMID 19124418. Arhivirano iz originala na datum 2012-12-04. Pristupljeno 2009-06-20.
William J. Elliott (October 2003). „The Economic Impact of Hypertension”. The Journal of Clinical Hypertension 5 (4): 3–13. DOI:10.1111/j.1524-6175.2003.02463.x. PMID 12826765.
Coca A (2008). „Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)”. Clinical Drug Investigation 28 (4): 211–20. DOI:10.2165/00044011-200828040-00002. PMID 18345711.

hta.ac.uk

Law M, Wald N, Morris J (2003). „Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy”. Health Technol Assess 7 (31): 1–94. PMID 14604498. Arhivirano iz originala na datum 2011-03-04. Pristupljeno 2013-09-23.

medscape.com

emedicine.medscape.com

Gibson, Paul (30. 7. 2009.). „Hypertension and Pregnancy”. eMedicine Obstetrics and Gynecology. Medscape. Pristupljeno 16. 06. 2009.
Rodriguez-Cruz, Edwin; Ettinger, Leigh M (6. 4. 2010.). „Hypertension”. eMedicine Pediatrics: Cardiac Disease and Critical Care Medicine. Medscape. Pristupljeno 16. 06. 2009.

nice.org.uk

National Clinical Guidance Centre (August 2011). „7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations”. Hypertension (NICE CG 127). National Institute for Health and Clinical Excellence. str. 102. Arhivirano iz originala na datum 2013-07-23. Pristupljeno 22. 12. 2011.
„CG34 Hypertension - quick reference guide” (PDF). National Institute for Health and Clinical Excellence. 2006-06-28. Arhivirano iz originala na datum 2009-03-13. Pristupljeno 2009-03-04.

guidance.nice.org.uk

North of England Hypertension Guideline Development Group (2004-08-01). „Frequency of measurements”. Essential hypertension (NICE CG18). National Institute for Health and Clinical Excellence. str. 53. Arhivirano iz originala na datum 2012-07-14. Pristupljeno 2011-12-22.

publications.nice.org.uk

National Institute Clinical Excellence (2011). „1.5 Initiating and monitoring antihypertensive drug treatment, including blood pressure targets”. GC127 Hypertension: Clinical management of primary hypertension in adults. Arhivirano iz originala na datum 2013-05-15. Pristupljeno 2011-12-23.

nih.gov

ncbi.nlm.nih.gov

Carretero OA, Oparil S (January 2000). „Essential hypertension. Part I: Definition and etiology”. Circulation 101 (3): 329–35. DOI:10.1161/01.CIR.101.3.329. PMID 10645931.
Chobanian AV, Bakris GL, Black HR, et al. (December 2003). „Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure”. Hypertension 42 (6): 1206–52. DOI:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957.
Mancia G, De Backer G, Dominiczak A, et al. (September 2007). „2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension”. J. Hypertens. 25 (9): 1751–62. DOI:10.1097/HJH.0b013e3282f0580f. PMID 17762635.
Williams B, Poulter NR, Brown MJ, et al. (March 2004). „Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV”. J Hum Hypertens 18 (3): 139–85. DOI:10.1038/sj.jhh.1001683. PMID 14973512.
Dionne JM, Abitbol CL, Flynn JT (January 2012). „Hypertension in infancy: diagnosis, management and outcome”. Pediatr. Nephrol. 27 (1): 17–32. DOI:10.1007/s00467-010-1755-z. PMID 21258818.
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (September 2007). „High blood pressure trends in children and adolescents in national surveys, 1963 to 2002”. Circulation 116 (13): 1488–96. DOI:10.1161/CIRCULATIONAHA.106.683243. PMID 17846287.
„The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents”. Pediatrics 114 (2 Suppl 4th Report): 555–76. August 2004. PMID 15286277.
Wong T, Mitchell P (February 2007). „The eye in hypertension”. Lancet 369 (9559): 425–35. DOI:10.1016/S0140-6736(07)60198-6. PMID 17276782.
Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T, Papademetriou V (December 2010). „Hypertension crisis”. Blood Press. 19 (6): 328–36. DOI:10.3109/08037051.2010.488052. PMID 20504242.
Marik PE, Varon J (June 2007). „Hypertensive crises: challenges and management”. Chest 131 (6): 1949–62. DOI:10.1378/chest.06-2490. PMID 17565029.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (December 2002). „Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies”. Lancet 360 (9349): 1903–13. DOI:10.1016/S0140-6736(02)11911-8. PMID 12493255.
Singer DR, Kite A (June 2008). „Management of hypertension in peripheral arterial disease: does the choice of drugs matter?”. European Journal of Vascular and Endovascular Surgery 35 (6): 701–8. DOI:10.1016/j.ejvs.2008.01.007. PMID 18375152.
Zeng C, Villar VA, Yu P, Zhou L, Jose PA (April 2009). „Reactive oxygen species and dopamine receptor function in essential hypertension”. Clinical and Experimental Hypertension 31 (2): 156–78. DOI:10.1080/10641960802621283. PMID 19330604.
Vasan, RS; Beiser, A, Seshadri, S, Larson, MG, Kannel, WB, D'Agostino, RB, Levy, D (2002-02-27). „Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.”. JAMA: the journal of the American Medical Association 287 (8): 1003-10. PMID 11866648.
Lifton, RP; Gharavi, AG, Geller, DS (2001-02-23). „Molecular mechanisms of human hypertension.”. Cell 104 (4): 545-56. PMID 11239411.
He, FJ; MacGregor, GA (2009). „A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.”. Journal of human hypertension 23 (6): 363-84. PMID 19110538.
Haslam DW, James WP (2005). „Obesity”. Lancet 366 (9492): 1197–209. DOI:10.1016/S0140-6736(05)67483-1. PMID 16198769.
Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA et al. (2002). „Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program”. JAMA 288 (15): 1882–8. DOI:10.1001/jama.288.15.1882. PMID 12377087.
Vaidya A, Forman JP (November 2010). „Vitamin D and hypertension: current evidence and future directions”. Hypertension 56 (5): 774–9. DOI:10.1161/HYPERTENSIONAHA.109.140160. PMID 20937970.
Sorof J, Daniels S (October 2002). „Obesity hypertension in children: a problem of epidemic proportions”. Hypertension 40 (4): 441–447. DOI:10.1161/01.HYP.0000032940.33466.12. PMID 12364344. Pristupljeno 2009-06-03.
Lawlor, DA; Smith, GD (2005). „Early life determinants of adult blood pressure.”. Current opinion in nephrology and hypertension 14 (3): 259-64. PMID 15821420.
Grossman E, Messerli FH (January 2012). „Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension”. Am. J. Med. 125 (1): 14–22. DOI:10.1016/j.amjmed.2011.05.024. PMID 22195528.
Conway J (April 1984). „Hemodynamic aspects of essential hypertension in humans”. Physiol. Rev. 64 (2): 617–60. PMID 6369352.
Palatini P, Julius S (June 2009). „The role of cardiac autonomic function in hypertension and cardiovascular disease”. Curr. Hypertens. Rep. 11 (3): 199–205. PMID 19442329.
Andersson OK, Lingman M, Himmelmann A, Sivertsson R, Widgren BR (2004). „Prediction of future hypertension by casual blood pressure or invasive hemodynamics? A 30-year follow-up study”. Blood Press. 13 (6): 350–4. PMID 15771219.
Folkow B (April 1982). „Physiological aspects of primary hypertension”. Physiol. Rev. 62 (2): 347–504. PMID 6461865.
Struijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, le Noble FA, van Essen H (December 1992). „The microcirculation and hypertension”. J Hypertens Suppl 10 (7): S147–56. PMID 1291649.
Safar ME, London GM (August 1987). „Arterial and venous compliance in sustained essential hypertension”. Hypertension 10 (2): 133–9. PMID 3301662.
Schiffrin EL (February 1992). „Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture”. Hypertension 19 (2 Suppl): II1–9. PMID 1735561.
Chobanian AV (August 2007). „Clinical practice. Isolated systolic hypertension in the elderly”. N. Engl. J. Med. 357 (8): 789–96. DOI:10.1056/NEJMcp071137. PMID 17715411.
Zieman SJ, Melenovsky V, Kass DA (May 2005). „Mechanisms, pathophysiology, and therapy of arterial stiffness”. Arterioscler. Thromb. Vasc. Biol. 25 (5): 932–43. DOI:10.1161/01.ATV.0000160548.78317.29. PMID 15731494.
Navar LG (December 2010). „Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1998–2000; discussion 2015. DOI:10.1152/japplphysiol.00182.2010a. PMC 3006411. PMID 21148349.
Esler M, Lambert E, Schlaich M (December 2010). „Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension”. J. Appl. Physiol. 109 (6): 1996–8; discussion 2016. DOI:10.1152/japplphysiol.00182.2010. PMID 20185633.
Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (June 2009). „Endothelium-dependent contractions and endothelial dysfunction in human hypertension”. Br. J. Pharmacol. 157 (4): 527–36. DOI:10.1111/j.1476-5381.2009.00240.x. PMC 2707964. PMID 19630832.
Marchesi C, Paradis P, Schiffrin EL (July 2008). „Role of the renin-angiotensin system in vascular inflammation”. Trends Pharmacol. Sci. 29 (7): 367–74. DOI:10.1016/j.tips.2008.05.003. PMID 18579222.
Padwal RS, Hemmelgarn BR, Khan NA i dr.. (May 2009). „The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 25 (5): 279–86. DOI:10.1016/S0828-282X(09)70491-X. PMC 2707176. PMID 19417858.
Padwal RJ, Hemmelgarn BR, Khan NA i dr.. (June 2008). „The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 24 (6): 455–63. DOI:10.1016/S0828-282X(08)70619-6. PMC 2643189. PMID 18548142.
Padwal RS, Hemmelgarn BR, McAlister FA i dr.. (May 2007). „The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 23 (7): 529–38. DOI:10.1016/S0828-282X(07)70797-3. PMC 2650756. PMID 17534459.
Hemmelgarn BR, McAlister FA, Grover S i dr.. (May 2006). „The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 22 (7): 573–81. DOI:10.1016/S0828-282X(06)70279-3. PMC 2560864. PMID 16755312.
Hemmelgarn BR, McAllister FA, Myers MG i dr.. (June 2005). „The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk”. Canadian Journal of Cardiology 21 (8): 645–56. PMID 16003448.
Luma GB, Spiotta RT (May 2006). „Hypertension in children and adolescents”. Am Fam Physician 73 (9): 1558–68. PMID 16719248.
Williams, B; Poulter, NR, Brown, MJ, Davis, M, McInnes, GT, Potter, JF, Sever, PS, McG Thom, S, British Hypertension, Society (2004). „Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.”. Journal of human hypertension 18 (3): 139-85. PMID 14973512.
Whelton PK et al. (2002). „Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program”. JAMA 288 (15): 1882–1888. DOI:10.1001/jama.288.15.1882. PMID 12377087.
Siebenhofer, A; Jeitler, K, Berghold, A, Waltering, A, Hemkens, LG, Semlitsch, T, Pachler, C, Strametz, R, Horvath, K (2011-09-07). Siebenhofer, Andrea. ur. „Long-term effects of weight-reducing diets in hypertensive patients”. Cochrane database of systematic reviews (Online) 9: CD008274. DOI:10.1002/14651858.CD008274.pub2. PMID 21901719.
Blumenthal JA, Babyak MA, Hinderliter A i dr.. (January 2010). „Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study”. Arch. Intern. Med. 170 (2): 126–35. DOI:10.1001/archinternmed.2009.470. PMID 20101007.
Greenhalgh J, Dickson R, Dundar Y (October 2009). „The effects of biofeedback for the treatment of essential hypertension: a systematic review”. Health Technol Assess 13 (46): 1–104. PMID 19822104.
Rainforth MV, Schneider RH, Nidich SI, Gaylord-King C, Salerno JW, Anderson JW (December 2007). „Stress Reduction Programs in Patients with Elevated Blood Pressure: A Systematic Review and Meta-analysis”. Curr. Hypertens. Rep. 9 (6): 520–8. DOI:10.1007/s11906-007-0094-3. PMC 2268875. PMID 18350109.
Ospina MB, Bond K, Karkhaneh M i dr.. (June 2007). „Meditation practices for health: state of the research”. Evid Rep Technol Assess (Full Rep) (155): 1–263. PMID 17764203.
He, FJ; MacGregor, GA (2004). „Effect of longer-term modest salt reduction on blood pressure.”. Cochrane database of systematic reviews (Online) (3): CD004937. PMID 15266549.
Law M, Wald N, Morris J (2003). „Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy”. Health Technol Assess 7 (31): 1–94. PMID 14604498. Arhivirano iz originala na datum 2011-03-04. Pristupljeno 2013-09-23.
Eni C. Okonofua; Kit N. Simpson; Ammar Jesri; Shakaib U. Rehman; Valerie L. Durkalski; Brent M. Egan (2006-01-23). „Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals”. Hypertension 47 (2006;47:345): 345–51. DOI:10.1161/01.HYP.0000200702.76436.4b. PMID 16432045. Pristupljeno 2009-11-22.
Klarenbach, SW; McAlister, FA, Johansen, H, Tu, K, Hazel, M, Walker, R, Zarnke, KB, Campbell, NR, Canadian Hypertension Education, Program (2010). „Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension.”. The Canadian journal of cardiology 26 (5): e158-63. PMID 20485695.
Wright JM, Musini VM (2009). Wright, James M. ur. „First-line drugs for hypertension”. Cochrane Database Syst Rev (3): CD001841. DOI:10.1002/14651858.CD001841.pub2. PMID 19588327.
Sever PS, Messerli FH (October 2011). „Hypertension management 2011: optimal combination therapy”. Eur. Heart J. 32 (20): 2499–506. DOI:10.1093/eurheartj/ehr177. PMID 21697169.
Musini VM, Tejani AM, Bassett K, Wright JM (2009). Musini, Vijaya M. ur. „Pharmacotherapy for hypertension in the elderly”. Cochrane Database Syst Rev (4): CD000028. DOI:10.1002/14651858.CD000028.pub2. PMID 19821263.
Aronow WS, Fleg JL, Pepine CJ, et al. (May 2011). „ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension”. J. Am. Coll. Cardiol. 57 (20): 2037–114. DOI:10.1016/j.jacc.2011.01.008. PMID 21524875.
Calhoun DA, Jones D, Textor S i dr.. (June 2008). „Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research”. Hypertension 51 (6): 1403–19. DOI:10.1161/HYPERTENSIONAHA.108.189141. PMID 18391085.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005). „Global burden of hypertension: analysis of worldwide data”. Lancet 365 (9455): 217–23. DOI:10.1016/S0140-6736(05)17741-1. PMID 15652604.
Kearney PM, Whelton M, Reynolds K, Whelton PK, He J (January 2004). „Worldwide prevalence of hypertension: a systematic review”. J. Hypertens. 22 (1): 11–9. PMID 15106785.
Burt VL, Whelton P, Roccella EJ i dr.. (March 1995). „Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991”. Hypertension 25 (3): 305–13. PMID 7875754. Arhivirano iz originala na datum 2012-12-05. Pristupljeno 2009-06-05.
Burt VL, Cutler JA, Higgins M i dr.. (July 1995). „Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991”. Hypertension 26 (1): 60–9. PMID 7607734. Arhivirano iz originala na datum 2012-12-20. Pristupljeno 2009-06-05.
Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S (July 2007). „Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004”. Journal of the American Geriatrics Society 55 (7): 1056–65. DOI:10.1111/j.1532-5415.2007.01215.x. PMID 17608879.
Lloyd-Jones D, Adams RJ, Brown TM, et al. (February 2010). „Heart disease and stroke statistics--2010 update: a report from the American Heart Association”. Circulation 121 (7): e46–e215. DOI:10.1161/CIRCULATIONAHA.109.192667. PMID 20019324.
Falkner B (May 2009). „Hypertension in children and adolescents: epidemiology and natural history”. Pediatr. Nephrol. 25 (7): 1219–24. DOI:10.1007/s00467-009-1200-3. PMC 2874036. PMID 19421783.
Luma GB, Spiotta RT (May 2006). „Hypertension in children and adolescents”. Am Fam Physician 73 (9): 1558–68. PMID 16719248. Arhivirano iz originala na datum 2007-09-26. Pristupljeno 2013-09-23.
Esunge PM (October 1991). „From blood pressure to hypertension: the history of research”. J R Soc Med 84 (10): 621. PMC 1295564. PMID 1744849.
Kotchen TA (October 2011). „Historical trends and milestones in hypertension research: a model of the process of translational research”. Hypertension 58 (4): 522–38. DOI:10.1161/HYPERTENSIONAHA.111.177766. PMID 21859967.
Dustan HP, Roccella EJ, Garrison HH (September 1996). „Controlling hypertension. A research success story”. Arch. Intern. Med. 156 (17): 1926–35. DOI:10.1001/archinte.156.17.1926. PMID 8823146.
Freis ED (1974). „The Veterans Administration Cooperative Study on Antihypertensive Agents. Implications for Stroke Prevention” (PDF). Stroke 5 (1): 76–77. DOI:10.1161/01.STR.5.1.76. PMID 4811316.
Chockalingam A (May 2007). „Impact of World Hypertension Day”. Canadian Journal of Cardiology 23 (7): 517–9. DOI:10.1016/S0828-282X(07)70795-X. PMC 2650754. PMID 17534457.
Chockalingam A (June 2008). „World Hypertension Day and global awareness”. Canadian Journal of Cardiology 24 (6): 441–4. DOI:10.1016/S0828-282X(08)70617-2. PMC 2643187. PMID 18548140.
Alcocer L, Cueto L (June 2008). „Hypertension, a health economics perspective”. Therapeutic Advances in Cardiovascular Disease 2 (3): 147–55. DOI:10.1177/1753944708090572. PMID 19124418. Arhivirano iz originala na datum 2012-12-04. Pristupljeno 2009-06-20.
William J. Elliott (October 2003). „The Economic Impact of Hypertension”. The Journal of Clinical Hypertension 5 (4): 3–13. DOI:10.1111/j.1524-6175.2003.02463.x. PMID 12826765.
Coca A (2008). „Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)”. Clinical Drug Investigation 28 (4): 211–20. DOI:10.2165/00044011-200828040-00002. PMID 18345711.

nhlbi.nih.gov

„Your Guide To Lowering Your Blood Pressure With DASH” (PDF). Pristupljeno 2009-06-08.

nps.org.au

„NPS Prescribing Practice Review 52: Treating hypertension”. NPS Medicines Wise. 2010-09-01. Pristupljeno 2010-11-05.

sagepub.com

tak.sagepub.com

Alcocer L, Cueto L (June 2008). „Hypertension, a health economics perspective”. Therapeutic Advances in Cardiovascular Disease 2 (3): 147–55. DOI:10.1177/1753944708090572. PMID 19124418. Arhivirano iz originala na datum 2012-12-04. Pristupljeno 2009-06-20.

web.archive.org

National Clinical Guidance Centre (August 2011). „7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations”. Hypertension (NICE CG 127). National Institute for Health and Clinical Excellence. str. 102. Arhivirano iz originala na datum 2013-07-23. Pristupljeno 22. 12. 2011.
North of England Hypertension Guideline Development Group (2004-08-01). „Frequency of measurements”. Essential hypertension (NICE CG18). National Institute for Health and Clinical Excellence. str. 53. Arhivirano iz originala na datum 2012-07-14. Pristupljeno 2011-12-22.
Law M, Wald N, Morris J (2003). „Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy”. Health Technol Assess 7 (31): 1–94. PMID 14604498. Arhivirano iz originala na datum 2011-03-04. Pristupljeno 2013-09-23.
National Institute Clinical Excellence (2011). „1.5 Initiating and monitoring antihypertensive drug treatment, including blood pressure targets”. GC127 Hypertension: Clinical management of primary hypertension in adults. Arhivirano iz originala na datum 2013-05-15. Pristupljeno 2011-12-23.
„2.5.5.1 Angiotensin-converting enzyme inhibitors”. British National Formulary. No. 62. 2011. Arhivirano iz originala na datum 2021-12-23. Pristupljeno 2011-12-22.
„CG34 Hypertension - quick reference guide” (PDF). National Institute for Health and Clinical Excellence. 2006-06-28. Arhivirano iz originala na datum 2009-03-13. Pristupljeno 2009-03-04.
Luma GB, Spiotta RT (May 2006). „Hypertension in children and adolescents”. Am Fam Physician 73 (9): 1558–68. PMID 16719248. Arhivirano iz originala na datum 2007-09-26. Pristupljeno 2013-09-23.

webmd.com

Shaw, Gina (2009-03-07). „Prehypertension: Early-stage High Blood Pressure”. WebMD. Pristupljeno 2009-07-03.

who.int

„Global health risks: mortality and burden of disease attributable to selected major risks.”. World Health Organization. 2009. Pristupljeno 10. 2. 2012.

wiley.com

onlinelibrary.wiley.com

He, FJ; MacGregor, GA (2004). „Effect of longer-term modest salt reduction on blood pressure.”. Cochrane database of systematic reviews (Online) (3): CD004937. PMID 15266549.

Hipertenzija (Serbo-Croatian Wikipedia)

aafp.org

ahajournals.org

hyper.ahajournals.org

circ.ahajournals.org

stroke.ahajournals.org

archive.org

archive.today

australianprescriber.com

bnf.org

chestpubs.org

chestjournal.chestpubs.org

doi.org

dx.doi.org

hta.ac.uk

medscape.com

emedicine.medscape.com

nice.org.uk

nice.org.uk

guidance.nice.org.uk

publications.nice.org.uk

nih.gov

ncbi.nlm.nih.gov

nhlbi.nih.gov

nps.org.au

sagepub.com

tak.sagepub.com

web.archive.org

webmd.com

who.int

wiley.com

onlinelibrary.wiley.com